PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

Share Price Information for Ovoca Bio (OVB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.725
Bid: 0.65
Ask: 0.80
Change: 0.00 (0.00%)
Spread: 0.15 (23.077%)
Open: 0.725
High: 0.725
Low: 0.725
Prev. Close: 0.725
OVB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

16 Aug 2016 12:00

RNS Number : 3162H
Ovoca Gold PLC
16 August 2016
 

Ovoca Gold PLC

16 August 2016

 

Ovoca Gold plc ("Ovoca" or the "Company")

2016 Interim Results

 

Ovoca Gold is pleased to announce its interim financial statements and report covering the six-month period from 1 January 2016 to 30 June 2016.

 

Please click on the following link to view the full Half Year Report:

 

http://www.rns-pdf.londonstockexchange.com/rns/3162H_-2016-8-16.pdf

 

Highlights:

 

· Cash and cash equivalents and available for sale financial assets of Euro 26.7 million as at 30 June 2016;

· Total comprehensive profit for the six-month period to 30 June 2016 of Euro 6.4 million;

· Dividend income received during the period of US$122,000 from our holding of Polymetal International Plc shares; and

· Cash payment of Euro 0.7 million received during the period relating to the Taymura LLC debt, which we continue to pursue through bankruptcy proceedings.

 

 

 

CEO's Statement

 

Dear shareholders,

 

It is my pleasure to report to you our financials and the results of our work for the first half of 2016.

 

The global market recovery of the gold mining sector positively reflected on our investment portfolio and boosted our financial position. This sector recovery has also brought renewed attention to our Stakhanovsky project. Management is using this time to continue the search for an investor for the Stakhanovsky project.

 

In addition to our gold activities, we also remained very active with litigation regarding our outstanding loan to Taymura LLC, which was declared bankrupt in February 2016. During the six-month period to 30 June 2016, Ovoca recovered US$740,621 in respect of assigned receivables in relation to this loan. Despite the unconstructive legal tactics Taymura LLC beneficiaries have been using, management still believes there is a strong chance to achieve substantial repayment of the Company's loan. We will continue to vigorously defend our interests in the bankruptcy procedure of Taymura LLC and seek all legal options available to us for the benefit of the Company.

 

Ovoca has a strong balance sheet and is entering a market upturn in commodities. As such, management is positive for 2016 and looks forward the next half of the year.

 

 

Sincerely,

 

Kirill Golovanov

CEO

 

ENDS

 

Enquiries:

 

Ovoca Gold plc

Kirill Golovanov, Chief Executive Officer

 

Tel: + 7 495 916 6029

Davy - NOMAD, ESM Adviser and Broker

Tel: +353 (1) 679 6363

John Frain / Daragh O'Reilly

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR EAEPKFLFKEFF
Date   Source Headline
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.